UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003934
Receipt No. R000004730
Scientific Title To decide Recommended dose of XELIRI and bevacizumab in patients with metastatic colorectal cancer who have oxlplatin based first-line chemotherapy including treatment failure or refractory, and To evaluate the safety and efficacy -PhaseI/II Study
Date of disclosure of the study information 2010/08/01
Last modified on 2017/06/24 18:52:54

No. Disposal Last modified on Item of update
1 Insert 2010/07/21 16:45:17
2 Update 2012/02/01 10:20:32 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Email
Organization
Organization
Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2014/07/21 14:38:30 Recruitment status
4 Update 2016/07/06 16:38:11 UMIN ID1
5 Update 2017/06/24 15:17:35 Recruitment status
Publication of results
6 Update 2017/06/24 18:52:54 URL related to results and publications


Contact us.